We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ConocoPhillips
COP
$147B
| $25.1M | 0.4% |
360,098
-56,786
| -14% | -$3.78M |
|
|
WUBA
52
DELISTED
58.com Inc
WUBA
| $25M | 0.4% |
361,000
+43,500
| +14% | +$3.55M |
|
53
Rockwell Automation
ROK
$51.4B
| $25M | 0.4% |
150,500
+23,069
| +18% | +$4.01M |
|
54
BioMarin Pharmaceuticals
BMRN
$11.5B
| $25M | 0.4% |
265,293
+55,500
| +26% | +$4.86M |
|
55
NVIDIA
NVDA
$5.01T
| $24.4M | 0.39% |
4,123,000
+734,000
| +22% | +$4.46M |
|
56
McCormick & Company Non-Voting
MKC
$13.4B
| $24.4M | 0.39% |
420,010
-27,014
| -6% | -$1.42M |
|
57
F5
FFIV
$22.1B
| $23.5M | 0.37% |
136,119
-60,662
| -31% | -$10.1M |
|
58
Mastercard
MA
$477B
| $23.2M | 0.37% |
118,015
+4,160
| +4% | +$782K |
|
59
Credicorp
BAP
$30.9B
| $22.8M | 0.36% |
101,200
+18,400
| +22% | +$4.18M |
|
60
Palo Alto Networks
PANW
$264B
| $22.7M | 0.36% |
661,962
+72,516
| +12% | +$2.42M |
|
61
Eli Lilly
LLY
$1.07T
| $22.6M | 0.36% |
264,953
-52,737
| -17% | -$4.33M |
|
62
Arista Networks
ANET
$219B
| $22.4M | 0.36% |
1,394,816
+157,808
| +13% | +$2.58M |
|
63
Intel
INTC
$466B
| $22M | 0.35% |
442,111
+7,696
| +2% | +$409K |
|
64
Humana
HUM
$46.7B
| $21.9M | 0.35% |
73,708
+17,186
| +30% | +$5.03M |
|
65
Travelers Companies
TRV
$80.8B
| $21.7M | 0.34% |
177,710
-34,735
| -16% | -$4.55M |
|
66
Occidental Petroleum
OXY
$57B
| $21.2M | 0.34% |
253,689
+113,452
| +81% | +$9.06M |
|
67
Pfizer
PFE
$140B
| $21.2M | 0.34% |
615,454
-215,920
| -26% | -$7.38M |
|
68
Weibo
WB
$1.9B
| $21.2M | 0.34% |
238,600
+6,400
| +3% | +$696K |
|
69
Prudential Financial
PRU
$41.7B
| $21.2M | 0.33% |
226,267
+35,438
| +19% | +$3.58M |
|
70
Micron Technology
MU
$1.04T
| $20.9M | 0.33% |
397,670
+25,660
| +7% | +$1.39M |
|
71
Baidu
BIDU
$35.8B
| $20.4M | 0.32% |
84,138
+11,428
| +16% | +$2.85M |
|
72
Autodesk
ADSK
$44.3B
| $19.9M | 0.32% |
152,179
+32,183
| +27% | +$4.26M |
|
73
Waste Management
WM
$95.9B
| $19.9M | 0.32% |
244,935
-55,530
| -18% | -$4.6M |
|
74
Incyte
INCY
$23.5B
| $19.9M | 0.31% |
296,860
+2,067
| +0.7% | +$141K |
|
75
Philip Morris
PM
$301B
| $19.7M | 0.31% |
244,478
-45,829
| -16% | -$3.89M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.